Saturday 25 Oct 2014

Mid Day Stock Recap: EGHT, SKUL, KLAC, OSK, BDR

New York, NY — (NISMAGAZINE) — 01/25/2013 — HotStockProfits.com issues special report on the top OTC stock movers – 8×8, Inc. (NASDAQ:EGHT), Skullcandy Inc (NASDAQ:SKUL), KLA-Tencor Corporation (NASDAQ:KLAC), Oshkosh Corporation (NYSE:OSK), Blonder Tongue Labs, Inc. (NYSEAMEX:BDR)

8×8, Inc. (NASDAQ:EGHT) shares fell 11.08% to $7.06 after the company’s third quarter total revenue increased 17% year-over-year to a record $27.3 million from $23.3 million in the same period of fiscal 2012. GAAP net income was $1.9 million, or $0.03 per diluted share, compared with $2.6 million, or $0.04 per share, for the same period last year. Non-GAAP net income (as outlined in the reconciliation table below) was $3.8 million, or $0.05 per diluted share, compared with $3.7 million, or $0.05 per diluted share, in the same period a year ago.

How Should Investors Trade EGHT After Today’s Slump? Find Out Here 

Skullcandy Inc (NASDAQ:SKUL) shares declined 1.46% to $6.74 in the morning hour. The company could be an acquisition target because its stock price has fallen by two thirds since it began trading in July, 2011. David King, an analyst for Roth Capital, told Bloomberg the company’s management may not be pushing for a sale, but added “you can’t ignore” the possibility of a deal “when the stock’s trading where it is and the value being as cheap as it is.

How To Trade SKUL After The Recent Momentum? Find Out Here

KLA-Tencor Corporation (NASDAQ:KLAC) stock jumped 9.20% to $56.75 after the company reported a second quarter profit of $106.6 million, or 63 cents a share, down from $110.8 million, or 66 cents a share, a year earlier. Adjusted earnings were also 63 cents a share, down from 72 cents a year ago. Revenue climbed 4.8% to $673 million, while product revenue increased 4.5% to $523 million.

Additionally, the company expects third quarter of 2013 revenue to be in the range of $690 million to $750 million and non-GAAP earnings per share (EPS) in the range of $0.76 to $0.96 assuming an effective tax rate of 18% in the march quarter to account for the reinstatement of the R&D tax credit. Analysts were expecting the Company to report revenues of $724 million and EPS of $0.86 for third quarter of 2013.

Get Free Trend Analysis On KLAC Here 

Oshkosh Corporation (NYSE:OSK) shares jumped 13.77% to $39.35 after the company reported first quarter net income of $46.2 million, or $0.51 per diluted share, as compared to $38.9 million, or $0.43 per diluted share, in the first quarter of fiscal 2012. Adjusted first quarter net income was $55.1 million, or $0.60 per diluted share, compared to $34.6 million, or $0.39 per diluted share, in the first quarter of fiscal 2012. Consolidated net sales in the first quarter of fiscal 2013 were $1.76 billion, a decrease of 6.1% compared to the prior year first quarter.

Is OSK A Buy The Yesterday’s Rally? Find Out Here

Blonder Tongue Labs, Inc. (NYSEAMEX:BDR) shares gained 10.87% to $1.53. The 52 week trading range for the company is $0.85 – $1.69. The shares of the company gained 12% in the last one year. BDR is a technology-development and manufacturing company that delivers television signal encoding, transcoding, digital transport and broadband product solutions for a range of applications.

About HotStockProfits.com

Subscribe for FREE to receive our “50 Stock Trading Rules No Hedge Fund Wants You To Know!” E-Book: http://hotstockprofits.com/trade-alert/

HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:

HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.

Contact:

 Edmund Kaminski

edmundkaminski@gmail.com

Leave a Comment